US OptionsDetailed Quotes
CACI241220P440000
- 4.70
- +0.62+15.20%
15min DelayClose Nov 27 15:59 ET
5.11High4.70Low
5.11Open4.08Pre Close3 Volume21 Open Interest440.00Strike Price1.49KTurnover28.45%IV5.43%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier22DDays to Expiry4.70Extrinsic Value100Contract SizeAmericanOptions Type-0.2367Delta0.0097Gamma100.06Leverage Ratio-0.2157Theta-0.0606Rho-23.68Eff Leverage0.3469Vega
CACI International Stock Discussion
Sign in to post a comment
$CACI International (CACI.US)$ 👀 good i see my risk and snipping goal clearly .
In assessing CACI's risk level, iits stable profitability, sound financial metrics, and manageable debt despite not being in a hot sector possess moderate risk. Its technical position near key levels suggests consistent support, minimizing downside risk. Current news enhances its prospects, while the stock's calculated breakout offers potential for gains. However, the general market volatility and macroeconomic condit...
In assessing CACI's risk level, iits stable profitability, sound financial metrics, and manageable debt despite not being in a hot sector possess moderate risk. Its technical position near key levels suggests consistent support, minimizing downside risk. Current news enhances its prospects, while the stock's calculated breakout offers potential for gains. However, the general market volatility and macroeconomic condit...
3
1
Yesterday they were awarded a 8 million contract for their support with The Navel Sea Systems. This could cause a major spike today. JS
4
The company's five-year track record of earnings growth has earned it high regard among market participants. Despite slower EPS growth relative to share price increase, it remains a business to watch in the long term.
1
CACI International's ROE appears acceptable with growth partly due to this. Although lagging industry growth, substantial reinvestment at high return rates drive respectable earnings growth. Analysts predict similar future earnings growth.
The company's earnings growth track record may have caused improved market views over the past five years. Its recent performance shows potential improvement as indicated by a superior one-year total shareholder return compared to a five-year TSR.
Despite modest insider sharing at CACI International, present patterns hint caution. Absence of insider buying in recent months raises concerns.
Our Call
What's next for A&D? Next RKLB Electron launch scheduled for later in August. Defense budget discussion likely on hold with Congress on recess until September. DSEI defense conference 9/12-9/15 in London. HWM plant tour/investor meeting 9/20.
Positive on aero:
Commercial aerospace remains one of the best multi-year growth stories in industrials, in our view, with pent-up demand for aircraft driving production higher and ...
What's next for A&D? Next RKLB Electron launch scheduled for later in August. Defense budget discussion likely on hold with Congress on recess until September. DSEI defense conference 9/12-9/15 in London. HWM plant tour/investor meeting 9/20.
Positive on aero:
Commercial aerospace remains one of the best multi-year growth stories in industrials, in our view, with pent-up demand for aircraft driving production higher and ...
+3
1
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Capri Holdings (CPRI.US)$ - up 51.8%
2. $Applovin (APP.US)$ - up 9.9%
3. $CyberArk (CYBR.US)$ - up 3.4%
4. $Sasol (SSL.US)$ - up 2.6%
5. $Banco Bilbao Vizcaya Argentaria (BBVA.US)$ - up 2.4%
6. $Telefonica (TEF.US)$ - up 1.6%
7. $Banco Santander (SAN.US)$ - up 1.3%
8. $Global Payments (GPN.US)$ - up 1.3%...
Gap Ups
1. $Capri Holdings (CPRI.US)$ - up 51.8%
2. $Applovin (APP.US)$ - up 9.9%
3. $CyberArk (CYBR.US)$ - up 3.4%
4. $Sasol (SSL.US)$ - up 2.6%
5. $Banco Bilbao Vizcaya Argentaria (BBVA.US)$ - up 2.4%
6. $Telefonica (TEF.US)$ - up 1.6%
7. $Banco Santander (SAN.US)$ - up 1.3%
8. $Global Payments (GPN.US)$ - up 1.3%...
+13
12
Gapping up
In reaction to earnings/guidance:
• $ChargePoint (CHPT.US)$ +2.8%, $Designer Brands (DBI.US)$ +1.8%, $Donaldson (DCI.US)$ +0.7%
Other news:
• $Cepton (CPTN.US)$ +9.2% (receives non-bindingLolfor a $100mln investment from Koito Manufacturing)
• $Sorrento Therapeutics (SRNE.US)$ +7.2% (receives FDA Fast Track Designation for SP-103(Lidocaine Topical System) 5.4%)
• $Mereo BioPharma (MREO.US)$ +6.7% (sends letter to Rubric Capital...
In reaction to earnings/guidance:
• $ChargePoint (CHPT.US)$ +2.8%, $Designer Brands (DBI.US)$ +1.8%, $Donaldson (DCI.US)$ +0.7%
Other news:
• $Cepton (CPTN.US)$ +9.2% (receives non-bindingLolfor a $100mln investment from Koito Manufacturing)
• $Sorrento Therapeutics (SRNE.US)$ +7.2% (receives FDA Fast Track Designation for SP-103(Lidocaine Topical System) 5.4%)
• $Mereo BioPharma (MREO.US)$ +6.7% (sends letter to Rubric Capital...
9
No comment yet
Inner Yo : That is neither the current price ($463.38) nor an accurate current assessment of news.